Opinion: Antihypertensive treatment can prevent stroke and cognitive decline

Nature Reviews Neurology

Volumn 9, Issue 3, 2013, Pages 174-178

  Sörös, Peter ^a   Whitehead, Shawn ^b   Spence, J David ^c   Hachinski, Vladimir ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; INDAPAMIDE; PERINDOPRIL;

ADULT; ALZHEIMER DISEASE; ARTERIOSCLEROSIS; ARTIFICIAL EMBOLISM; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEMENTIA; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE CONTROL; GERIATRIC PATIENT; HEALTH SURVEY; HUMAN; HYPERTENSION; INSULA; LACUNAR STROKE; MINI MENTAL STATE EXAMINATION; MORBIDITY; MORTALITY; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSTATIC HYPOTENSION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; ARTICLE;

COGNITION DISORDERS; HUMANS; HYPERTENSION; STROKE;

EID: 84874948266     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2012.255     Document Type: Review

References (44)

1. Lawes, C. M., Vander Hoorn, S. & Rodgers, A. Global burden of blood pressure related disease, 2001. Lancet 371, 1513-1518 (2008).
2. Lewington, S. et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903-1913 (2002).
3. Li, C., Engström, G., Hedblad, B., Berglund, G. & Janzon, L. Risk factors for stroke in subjects with normal blood pressure: a prospective cohort study. Stroke 36, 234-238 (2005).
4. Spence, J. D. Antihypertensive drugs and prevention of atherosclerotic stroke. Stroke 17, 808-810 (1986).
5. Roger, V. L. et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 125, e2-e220 (2012).
6. Birns, J. & Kalra, L. Cognitive function and hypertension. J. Hum. Hypertens. 23, 86-96 (2009).
7. Schiller, J. S., Lucas, J. W., Ward, B. W. & Peregoy, J. A. Summary health statistics for U.S. adults: National Health Interview Survey, 2010. Vital Health Stat. 10, 1-207 (2012).
8. Pantoni, L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 9, 689-701 (2010).
9. Hachinski, V. & Norris, J. W. The Acute Stroke 1-286 (F. A. Davis, Philadelphia, 1985).
10. O'Rourke, M. F. & Safar, M. E. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 46, 200-204 (2005).
11. Labovitz, D. L., Halim, A., Boden-Albala, B., Hauser, W. A. & Sacco, R. L. The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics. Neurology 65, 518-522 (2005).
12. Vermeer, S. E. et al. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 34, 392-396 (2003).
13. Das, R. R. et al. Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke 39, 2929-2935 (2008).
14. Spence, J. D. Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol. 6, 830-838 (2007).
15. Poli, D. et al. Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: the role of homocysteine. Stroke 36, 2159-2163 (2005).
16. Böger, R. H., Bode-Böger, S. M., Sydow, K., Heistad, D. D. & Lentz, S. R. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 20, 1557-1564 (2000).
17. Snowdon, D. A. et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277, 813-817 (1997).
18. Skoog, I., Andreasson, L. A., Landahl, S. & Lernfelt, B. A population-based study on blood pressure and brain atrophy in 85 year olds. Hypertension 32, 404-409 (1998).
19. Peters, R. et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol. 7, 683-689 (2008).
20. Oveisgharan, S. & Hachinski, V. Hypertension, executive dysfunction, and progression to dementia: the Canadian study of health and aging. Arch. Neurol. 67, 187-192 (2010).
21. Whitehead, S. N., Cheng, G., Hachinski, V. C. & Cechetto, D. F. Progressive increase in infarct size, neuroinflammation, and cognitive deficits in the presence of high levels of amyloid. Stroke 38, 3245-3250 (2007).
22. Whitehead, S. N., Hachinski, V. C. & Cechetto, D. F. Interaction between a rat model of cerebral ischemia and β-amyloid toxicity: inflammatory responses. Stroke 36, 107-112 (2005).
23. Whitehead, S., Cheng, G., Hachinski, V. & Cechetto, D. F. Interaction between a rat model of cerebral ischemia and β-amyloid toxicity: II. Effects of triflusal. Stroke 36, 1782-1789 (2005).
24. Whitehead, S. N. et al. Triflusal reduces cerebral ischemia induced inflammation in a combined mouse model of Alzheimer's disease and stroke. Brain Res. 1366, 246-256 (2010).
25. Musini, V. M., Tejani, A. M., Bassett, K. & Wright, J. M. Pharmacotherapy for hypertension in the elderly. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD000028. http://dx.doi.org/10.1002/14651858. CD000028.pub2.
26. Beckett, N. S. et al. Treatment of hypertension in patients 80 years of age or older. N. Engl. J. Med. 358, 1887-1898 (2008).
27. Lewington, S., Clarke, R., Qizilbash, N., Peto, R. & Collins, R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903-1913 (2002).
28. Rothwell, P. M., Howard, S. C. & Spence, J. D. Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke 34, 2583-2590 (2003).
29. Lee, M., Saver, J. L., Hong, K. S., Hao, Q. & Ovbiagele, B. Does achieving an intensive versus usual blood pressure level prevent stroke? Ann. Neurol. 71, 133-140 (2012).
30. McGuinness, B., Todd, S., Passmore, P. & Bullock, R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD004034.http://dx.doi.org/10.1002/14651858.CD004034.pub3.
31. Pendlebury, S. T., Cuthbertson, F. C., Welch, S. J., Mehta, Z. & Rothwell, P. M. Underestimation of cognitive impairment by Mini-Mental State Examination versus the Montreal Cognitive Assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke 41, 1290-1293 (2010).
32. Hachinski, V. et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37, 2220-2241 (2006).
33. Forette, F. et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch. Intern. Med. 162, 2046-2052 (2002).
34. Spence, J. D., Sibbald, W. J. & Cape, R. D. Pseudohypertension in the elderly. Clin. Sci. Mol. Med. Suppl. 4, 399s-402s (1978).
35. Spence, J. D., Sibbald, W. J. & Cape, R. D. Direct, indirect and mean blood pressures in hypertensive patients: the problem of cuff artefact due to arterial wall stiffness, and a partial solution. Clin. Invest. Med. 2, 165-173 (1979).
36. Spence, J. D. Pseudohypertension. Hypertension 59, e49 (2012).
37. Stewart, R. et al. Change in blood pressure and incident dementia: a 32-year prospective study. Hypertension 54, 233-240 (2009).
38. Royall, D. R., Gao, J. H. & Kellogg, D. L. Jr. Insular Alzheimer's disease pathology as a cause of "age-related" autonomic dysfunction and mortality in the non-demented elderly. Med. Hypotheses 67, 747-758 (2006).
39. Sörös, P., Inamoto, Y. & Martin, R. E. Functional brain imaging of swallowing: an activation likelihood estimation meta-analysis. Hum. Brain Mapp. 30, 2426-2439 (2009).
40. Oppenheimer, S. M., Gelb, A., Girvin, J. P. & Hachinski, V. C. Cardiovascular effects of human insular cortex stimulation. Neurology 42, 1727-1732 (1992).
41. Sörös, P. & Hachinski, V. Cardiovascular and neurological causes of sudden death after ischaemic stroke. Lancet Neurol. 11, 179-188 (2012).
42. Braak, H. & Braak, E. Evolution of neuronal changes in the course of Alzheimer's disease. J. Neural Transm. Suppl. 53, 127-140 (1998).
43. Yusuf, S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364, 937-952 (2004).
44. O'Donnell, M. J. et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376, 112-123 (2010).